Drug intelligence / Profile preview

xenon (129xe)

Development stage
Approved
Lead developer
Xemed
Modality
Small Molecules
Administration
Inhalation
01

Overview

MagniXene is a hyperpolarized xenon-129 (129Xe) gas contrast agent developed by Xemed LLC for use in functional magnetic resonance imaging (MRI) of the lungs. The gas is hyperpolarized using spin-exchange optical pumping (SEOP) to significantly enhance its nuclear magnetic resonance signal, allowing for high-resolution, non-invasive visualization of pulmonary ventilation, gas distribution, and alveolar-capillary gas exchange. MagniXene is primarily utilized in clinical research to assess regional lung function in patients with chronic obstructive pulmonary disease (COPD), asthma, and other interstitial lung diseases, providing insights into disease progression and the efficacy of therapeutic interventions such as Targeted Lung Denervation (TLD). It is typically used in conjunction with a specialized polarizer system, such as Xemed's MagniPolarizer.

Brand names
MagniXene
Other names
hyperpolarized xenon-129129XeHP 129XeHP129XeHP-129Xe

Beyond the preview

Go deeper on xenon (129xe).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xenon (129xe).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call